The main objective is to train young scientists in rational design of glycoconjugates.


The main objective of GLYCOVAX is to train young scientists to use and combine the different state-of-the-art methodologies for the rational design of glycoconjugates that can improve current vaccines and/or tackle unmet medical needs. To accomplish its mission, GLYCOVAX’s research plan is organized in 4 well-interconnected research workpackages (WP 1-4), supported by 4 additional workpackages including coordination and management (WP5), recruitment (WP6), training (WP7) and dissemination and public engagement (WP8) activities. These interconnected objectives will allow the selection of rationally designed vaccine candidates. The GLYCOVAX approach will be applied to epidemiologically relevant disease areas: meningitis (Neisseria meningitidis, Haemophilus influenzae), neonatal infections (Group B streptococci), and nosocomial infections (Enterococci, Staphylococcus aureus).

GLYCOVAX will involve 14 PhD projects well integrated in the four research work packages and interconnected among them.

Meningitis Neonatal infections Neonatal infections
WP1: Carbohydrate synthesis
ESR 3, 15
ESRs 1, 2, 5, 7 ,8
ESRs 4
WP2: Study of carbohydrate-protein interactions
ESRs 9, 11, 12
ESRs 8, 9, 10, 11, 12
ESRs 4
WP3: Novel glycoconjugation methods
ESR 13, 15
ESRs 1, 2, 3, 5, 7, 13
ESRs 4, 14
WP4: Study of immunogenicity-structure relationship
ESRs 3, 10, 15
ESRs 9, 10
ESRs 4, 10, 14


Back to home